Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 562 M508 M522 M631 M582 M513 M 2.25 B Research & development —————— — Operating income 945 M1.33 B1.7 B934 M1.16 B1.31 B 5.11 B Non-Operating Income, Total -210 M-115 M-123 M74 M-6 M8 M -47 M Interest expense, net of interest capitalized 249 M228 M248 M267 M278 M236 M 1.03 B Non-Operating Income, excl. Interest Expenses -199 M-109 M-87 M-247 M-286 M-235 M -855 M Unusual income/expense -11 M-6 M-36 M37 M2 M7 M 10 M Pretax income 751 M1.09 B1.49 B4.47 B976 M1.15 B 8.09 B Equity in earnings 48 M107 M158 M101 M84 M67 M 410 M Taxes 16 M5 M11 M3 M26 M14 M 54 M Non-controlling/minority interest 6 M5 M4 M8 M8 M8 M 28 M After tax other income/expense —————— — Net income before discontinued operations 730 M1.21 B1.57 B753 M941 M1.13 B 4.4 B Discontinued operations —————— — Net income 730 M1.21 B1.57 B753 M941 M1.13 B 4.4 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 745 M1.21 B1.57 B753 M941 M1.13 B 4.4 B Basic earnings per share (Basic EPS) 2.714.455.792.83.494.21 16.29 Diluted earnings per share (Diluted EPS) 2.74.415.742.763.484.2 16.18 Average basic shares outstanding 269 M272 M272 M271 M270 M268 M — Diluted shares outstanding 276 M275 M274 M274 M271 M268 M — EBITDA 970 M1.35 B1.73 B957 M1.22 B— — EBIT 946 M1.33 B1.7 B932 M1.16 B1.31 B 5.11 B Cost of revenue 2.08 B2.28 B2.48 B2.24 B2.25 B2.55 B 9.52 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 24 M24 M27 M25 M53 M-39 M 66 M